NOVEL PHENYL AND PYRIDYL UREAS ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)
LaoBiz.com profiles the Laos Patent “NOVEL PHENYL AND PYRIDYL UREAS ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV)” from open registry fields, filed by AiCuris GmbH & Co.KG on 2021-10-14; current status: Awaiting formal examination. Identifiers include application No. P/805; DIP id LAP805; protection kind Patent - PCT National Phase. Key dates: publication 2026-01-30. Classification: A61K 31/4162、A61K 31/4188、A61K 31/42、C07D 471/04、C07D 471/18、C07D 487/04、C07D 498/04. Inventor(s)/designer(s): BONSMANN, Susanne, DONALD, Alastair, KLENKE, Burkhard, SPRINGER, Jasper, URBAN, Andreas. Abstract hint: The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhib…. Unique application identifiers, holders and classification text are surfaced here to reduce near-duplicate IP landing pages; always verify against the competent office.
P/805
Mark
Key facts
- Type
- Patent
- App. no.
P/805- Status
- Awaiting formal examination
- Applicant
- AiCuris GmbH & Co.KG
- Agent
- Lao Trademark Agency
- Filing date
- 2021-10-14
- Publication
- 2026-01-30
- Protection kind
- Patent - PCT National Phase
- Priority
- GB · 09172007.7 · 2019-04-30；GB · 19172401.2 · 2019-05-02
- Applicant address
- AiCuris GmbH & Co.KG · Friedrich-Ebert-StraBe 475 DE / 12117 Wuppertal Germany · DE
- Agent address
- Lao Trademark Agency · 148-149 Ban Sisavath Kang, Unit 16 Chanthabury District, P.O. Box: 925, Vientiane · LA
- Nice / IPC classes
- A61K 31/4162 · A61K 31/4188 · A61K 31/42 · C07D 471/04 · C07D 471/18 · C07D 487/04 · C07D 498/04
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds which can inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV replication cycle, compositions comprising such compounds, methods for inhibiting HBV viral replication, methods for treating or preventing HBV infection, and processes and intermediates for making the compounds.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP805.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP805.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP805.html?lang=en · CC BY 4.0